The “International Precision Regenerative Medicine Symposium 2025” Successfully Held at MUST

Group Photo

The “International Precision Regenerative Medicine Symposium 2025” was successfully held on December 18, 2025, at the N101 Lecture Hall at Macau University of Science and Technology (MUST). The symposium was conducted in a hybrid format, combining on-site and online participation, and brought together leading experts in regenerative medicine, stem cell research, and translational innovation..

Distinguished officiating guests attending the event included: Dr. Vincent U Sang U, President of the Administrative Committeeof the Science and Technology Development Fund (FDCT), Macau SAR Government, Ms. Sio Wa TAM, Head of the Division of Tertiary Educational Cooperation and Exchange, Education and Youth Development Bureau, Macau SAR Government, Ms. Gloria Chak, Manager of Convention and Exhibition Industry Development Division of Macao Commerce and Investment Promotion Institute, Dr. Peng Bin LI, Director of Kiang Wu Hospital, Dr. Ka Kuen YUNG, Director of Macau YinKui Hospital, Dr. Wai Seng LEI, Vice President of Macao Medical Center of Islands Healthcare Complex – Macao Medical Center of Peking Union Medical College Hospital, Dr. Wai I NG, Vice President of Kiang Wu Nursing College.

Senior representatives from MUST included: Chair Professor Paul Kwong-Hang TAM, Vice President of MUST and Director of MUST Precision Regenerative Medicine Centre (PRMRC), , Chair Professor ZHU Yi Zhun, Associate Vice President and Director of School of Pharmacy of MUST, , Professor Manson Fok, President of University Hospital and Dean of Faculty of Medicine of MUST, and Professor Aliana LEONG Man Wai, Associate Vice President and Dean of the School of Liberal Arts of MUST.

Vice President Paul Kwong-Hang TAM delivered remarks

In his welcoming remarks, Chair Professor Paul Kwong-Hang Tam highlighted that since its establishment in 2023, PRMRC has aimed to build a focused and collaborative platform advancing stem cell biology, regenerative medicine, and translational innovation. He emphasised the Centre’s commitment to maintaining strong links between basic science, clinical research, and industry, as well as nurturing the next generation of scientists and clinicians. He noted that the symposium featured three key themes: Precision and Regenerative Hepatobiliary Medicine, Developmental and Genetic Foundations of Regeneration, and Translational Frontiers in Regenerative Medicine.

President Vincent U Sang U delivered remarks

Dr. Vincent U Sang U highlighted the importance of what he described as the “three Cs” of scientific advancement: connection, curiosity, and collaboration. He encouraged participants to make full use of the symposium as a platform to strengthen professional networks and to initiate new partnerships across disciplines and sectors. Dr. U also outlined the Macau SAR Government’s strategic plans to establish a technology research industrial park, with biomedicine identified as a key priority area, to further support the translation of scientific research into innovation and industrial development. In addition, he noted that Macau is deepening its integration with the Greater Bay Area, with more than 30 Guangdong–Hong Kong–Macau joint laboratories established in recent years, creating new opportunities for cross-regional collaboration in medical sciences and other research fields.

Opening Ceremony Photo

The symposium featured 11 internationally renowned speakers. The programme covered cutting-edge basic research, clinical advances, and industrial translation in precision regenerative medicine, promoting academic exchange and collaboration at local, national, and international levels. Invited speakers included Professor Paolo De Coppi of UCL Great Ormond Street Institute of Child Health, Professor Richard Thompson of King’s College London, Professor Fotios Sampaziotis of University of Cambridge, Professor Huck-Hui Ng of Genome Institute of Singapore, Professor Kathryn Song Eng Cheah of University of Hong Kong, Professor Xuejun Wen of Virginia Commonwealth University, Mr. Luo Yun of Zhongsheng Group, Associate Professor Toan Thang Phan of National University of Singapore, Professor Cheng-Lung Lin of Pell Biotech, Taiwan, Dr. Feng Liu of Benethera Biotechnology, Beijing, and Dr. Li Chen of Likang Life Sciences.

Panel discussions

At the panel discussion session, industry representatives shared cutting-edge research findings, clinical insights, and translational perspectives, contributing to in-depth discussions and panel exchanges that highlighted the future directions of precision regenerative medicine. Before the conclusion of the symposium, Ms. Irene Kan, Functional Head of the Investment Promotion Division of the Commerce and Investment Promotion Institute (IPIM) of the Macau SAR Government, delivered a presentation entitled “Policy Empowerment: The Business Advantages and Opportunities in Macao’s Health Industry.” In her talk, Ms. Kan outlined Macao’s strategic positioning and policy incentives for the development of the health and biomedical sectors, highlighting opportunities for investment, industry–academia collaboration, and technology translation. She emphasized how Macao’s business environment, regulatory framework, and regional connectivity provide a supportive platform for companies and research institutions seeking to establish or expand health-related initiatives in the region.

澳門科技大學成功舉辦“2025年國際精準再生醫學研討會”

研討會合照

“2025年國際精準再生醫學研討會”於2025年12月18日在澳門科技大學N101演講廳成功舉行。研討會以線上+線下方式舉行，雲集了再生醫學、幹細胞研究和轉化創新領域的頂尖專家。

出席活動的主禮嘉賓包括：澳門特別行政區政府科學技術發展基金行政委員會余雨生主席，澳門特別行政區政府教育及青年發展局高教合作交流處譚兆華處長，澳門招商投資促進局會展產業拓展處翟蕙珊經理，鏡湖醫院李鵬斌院長，澳門銀葵醫院翁家權院長，離島醫療綜合體北京協和醫院澳門醫學中心李偉成副院長，以及澳門鏡湖護理學院伍慧兒副院長。

澳科大大學管理層代表:澳科大副校長兼澳科大精準再生醫學中心總監譚廣亨講座教授，澳科大協理副校長兼藥學院院長朱依諄講座教授，澳科大醫院院長兼醫學院院長霍文遜教授, 以及澳科大協理副校長兼博雅學院院長梁文慧教授。

澳科大副校長兼澳科大中心主任譚廣亨講座教授致歡迎辭

譚廣亨副校長在歡迎辭中，指出精準再生醫學研究中心自2023年成立以來，始終以構建專注性協作科研平台為目標，致力於推動幹細胞生物學、再生醫學與轉化創新領域的發展。他強調，該中心一貫注重維繫基礎科學、臨床研究與產業界之間的緊密聯動，並積極培養下一代科學家與臨床醫生。此外，他還提及本次研討會設有三大核心主題：精準與再生肝膽醫學、再生的發育與遺傳基礎，以及再生醫學的轉化前沿。

澳門特別行政區政府科學技術發展基金行政委員會余雨生主席致歡迎辭

余雨生主席強調了他提出的科學進步「三個C」的重要性：聯繫、好奇心與合作。他鼓勵與會者充分利用研討會平台，加強專業網絡建設，並積極搭建跨學科、跨界別的新型合作夥伴關係。余主席隨後概述了澳門特區政府建設科技研究產業園的戰略規劃——將生物醫藥列為重點領域，進一步推動科研成果向創新應用與產業發展轉化。此外，他指出澳門正持續深化與大灣區的融合，近年已建成30多個粵港澳聯合實驗室，為醫學及其他研究領域的跨區域合作開闢了新機遇。

開幕儀式

研討會邀請了11位國際知名講者，他們的分享涵蓋精準再生醫學領域的前沿基礎研究、臨床進展與產業轉化方向，旨在推動本地、國家及國際層面的學術交流與合作。特邀講者包括倫敦大學學院大奧蒙德街兒童健康研究所Paolo De Coppi教授，倫敦國王學院Richard Thompson教授，劍橋大學Fotios Sampaziotis教授，新加坡科技研究局Huck-Hui Ng教授，香港大學謝賞恩教授，維吉尼亞聯邦大學文學軍教授，眾生集團羅雲先生，新加坡國立大學潘全勝副教授，臺灣沛爾生技醫藥股份有限公司林成龍教授，博迪賀康(北京)生物技術有限公司劉峰博士，以及北京立康生命科技有限公司陳立博士。

專家座談會

在專家座談會中，產業代表分享前沿的研究成果、臨床轉化與應用的新觀點，就業內的最新進展就行了深入的專題討論交流，進一步突顯出精準再生醫學的未來發展方向。在研討會結束前，澳門特別行政區招商投資促進局（IPIM）招商投資促進處職務主管簡婉君女士以 「政策賦能：澳門大健康產業的營商優勢與機遇」 為題發表演講。簡女士在演講中介紹了澳門在健康及生物醫藥產業發展方面的戰略定位與相關政策支持，並重點闡述了澳門在投資環境、法規制度及區域聯通性方面的優勢，為企業及科研機構在澳門落地及拓展健康產業項目、推動產學研合作與科技成果轉化提供了良好平台。